Diagnosis and management of sudden death in children

Frank A Fish1, Prince J Kannankeril

  • 1Department of Pediatrics, Thomas P. Graham Jr Division of Cardiology, Monroe Carell Jr Children's Hospital at Vanderbilt and Vanderbilt University School of Medicine, Nashville, Tennessee 37232-9119, USA. Frank.fish@vanderbilt.edu

Insights

Sudden death in children can often be linked to identifiable cardiac conditions. Molecular autopsy and family screening help identify at-risk individuals, enabling early intervention and potentially preventing future tragedies.

Area of Science:

  • Pediatric Cardiology
  • Forensic Pathology
  • Genetics

Background:

  • Sudden death is a significant cause of mortality in industrialized nations.
  • Sudden death in children, while less common, has profound familial and community impact.
  • Previously unexplained sudden deaths in children are increasingly linked to cardiac conditions.

Purpose of the Study:

  • To review recent advancements in understanding and identifying causes of sudden death in children.
  • To discuss the role of molecular autopsy and family investigation in diagnosing cardiac conditions.
  • To explore the controversial use of ECG screening and the impact of stimulant medications.

Main Methods:

  • Review of recent studies on sudden death in children.
  • Analysis of molecular autopsy findings and family investigations.
  • Discussion of ECG screening efficacy and risks associated with stimulant medications.

Main Results:

  • A portion of unexplained sudden deaths in children are due to identifiable cardiac conditions.
  • Molecular autopsy and family screening can identify at-risk relatives.
  • ECG screening and stimulant medication risks remain subjects of ongoing debate.

Conclusions:

  • Post-mortem genetic testing and family investigations are valuable for determining causes of sudden death in children.
  • Early identification of at-risk individuals is crucial due to available and emerging treatments.
  • The debate on universal ECG screening involves scientific, social, and political considerations.
Abstract

Related Concept Videos

Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Cardiopulmonary Resuscitation III: AED Use01:23

Cardiopulmonary Resuscitation III: AED Use

Introduction to AEDAn Automated External Defibrillator (AED) is a portable medical device that analyzes the heart's rhythm and, if necessary, delivers an electrical shock to help the heart re-establish an effective rhythm during sudden cardiac arrest (SCA). SCA occurs when the heart suddenly and unexpectedly stops beating, leading to a loss of blood flow to the brain and other vital organs. In such emergencies, time is of the essence, and using an AED, combined with Cardiopulmonary...
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
Dysrhythmias V: Evaluating Dysrhythmias01:30

Dysrhythmias V: Evaluating Dysrhythmias

Dysrhythmias, also known as arrhythmias, are disturbances in the heart's rhythm that range from benign to life-threatening. A thorough evaluation is crucial for appropriate management and involves a comprehensive medical history, physical examination, and various diagnostic tests.Medical HistorySymptoms: Collect detailed information on palpitations, dizziness, syncope, chest pain, and fatigue. Note their onset, frequency, and triggers.Previous Cardiac Issues: Document any history of heart...
Dysrhythmias VI: Management of Dysrhythmias01:25

Dysrhythmias VI: Management of Dysrhythmias

Dysrhythmia management involves a multifaceted approach, incorporating pharmacological treatments, medical procedures, surgical interventions, lifestyle modifications, and patient education.Pharmacological ManagementAntiarrhythmic Drugs:Class I (Sodium Channel Blockers): This class includes quinidine and procainamide, which reduce the speed of impulse conduction in the heart, stabilize the cardiac membrane, and control arrhythmias. Quinidine and procainamide are Class IA agents that prolong the...
Cardiopulmonary Resuscitation IV: Pharmacological Management01:25

Cardiopulmonary Resuscitation IV: Pharmacological Management

Pharmacologic intervention is crucial in treating cardiac arrest patients during ACLS or Advanced Cardiovascular Life Support. The ACLS algorithms guide the administration of specific drugs based on the patient's cardiac arrest rhythm, which includes pulseless ventricular tachycardia (VT), ventricular fibrillation (VF), asystole, and pulseless electrical activity (PEA).EpinephrineIndication: Epinephrine is the first-line drug for all cardiac arrest rhythms.Mechanism of Action: Epinephrine...